However, the regulation of known angiogenic inducers by WNT2 prevails in CAFs of CRC patients, thus leading to a shift in the angiogenic balance towards a pro-angiogenic milieu in the tumor stroma. This evidence concerns the gene WNT2 and colorectal carcinoma.